Literature DB >> 6869089

Immunity to Salmonella infection.

T K Eisenstein, B M Sultzer.   

Abstract

The foregoing literature review and data presentation have been set forth in the hope of clarifying some complex and confusing issues in regard to Salmonella infection. From a practical point of view, the information presented has implications for the direction to take with regard to improving the current typhoid vaccine, as the presently used acetone-killed cell preparation has considerable toxicity. The issues are important from a theoretical standpoint, because they have bearing on the nature of the concepts researchers and clinicians carry as working hypothesis with regard to the mechanisms of immunity to Salmonella infection. An incomplete appreciation of the literature seems to have led many scientists to believe that only cellular immunity can protect a mouse, and by analogy a human, against Salmonella. The logical deduction from such a premise is that only live vaccines will be effective in humans againsT S. typhi. Such a conclusion would appear unfounded, as documented in this review, for killed vaccines have been shown to be highly effective in vaccinating many mouse strains, as well as humans, against enteric fever.

Entities:  

Mesh:

Year:  1983        PMID: 6869089     DOI: 10.1007/978-1-4684-4481-0_26

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  18 in total

1.  Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice.

Authors:  A J Szalai; J L VanCott; J R McGhee; J E Volanakis; W H Benjamin
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Moderate immunodeficiency does not increase susceptibility to Salmonella typhimurium aroA live vaccines in mice.

Authors:  M Izhar; L DeSilva; H S Joysey; C E Hormaeche
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

3.  T cells do not mediate the initial suppression of a Salmonella infection in the RES.

Authors:  C E Hormaeche; P Mastroeni; A Arena; J Uddin; H S Joysey
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

4.  Altered expression of the Salmonella typhimurium-specific B-cell repertoire in mice chronically treated with antibodies to immunoglobulin D.

Authors:  M J Fultz; F D Finkelman; E S Metcalf
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

5.  Attenuation and vaccine potential of aroQ mutants of Corynebacterium pseudotuberculosis.

Authors:  C P Simmons; A L Hodgson; R A Strugnell
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Host response to infection with a temperature-sensitive mutant of Salmonella typhimurium in a susceptible and a resistant strain of mice.

Authors:  C Nauciel; F Vilde; E Ronco
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

7.  Antibody response and protection against challenge in mice vaccinated intraperitoneally with a live aroA O4-O9 hybrid Salmonella dublin strain.

Authors:  A A Lindberg; T Segall; A Weintraub; B A Stocker
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

8.  Gamma interferon and interleukin-10 gene expression in innately susceptible and resistant mice during the early phase of Salmonella typhimurium infection.

Authors:  S Pie; P Matsiota-Bernard; P Truffa-Bachi; C Nauciel
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  Specific and natural antibody production during Salmonella typhimurium infection in genetically susceptible and resistant mice.

Authors:  P Matsiota-Bernard; W Mahana; S Avrameas; C Nauciel
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

10.  Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine.

Authors:  D C Watson; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.